.

Browse Ovacome's webinars on the latest developments in ovarian cancer research and treatment:

• Updates in ovarian cancer research
• The era of individualised treatment in ovarian cancer
• PARP life
• Treating ovarian cancer with anti-angiogenic agents, such as bevacizumab (Avastin)
• The effectiveness of bevacizumab (Avastin) and related trials
• Managing ascites: current and future treatment options
• Prehabilitation: preparing your mind and body for cancer treatment

.

Updates in ovarian cancer research

A webinar with Dr Rowan Miller, Consultant Medical Oncologist specialising in gynae-oncology and early phase clinical trials at University College London and St Bartholomew's Hospitals. Recorded in September 2020. Please note the availability and eligibility criteria for some the therapies mentioned in this presentation may have changed since it was recorded. For up-to-date information on targeted therapies, head to our information page.

.

.

The era of individualised treatment in ovarian cancer

A webinar with Professor Sean Kehoe MD DCH FRCOG, Professor of Gynaecological Cancer and Lead Clinician at the Oxford Gynaecological Cancer Centre. Recorded in June 2022.

.

.

PARP Life

A webinar with three clinicians from Newcastle Upon Tyne NHS Trust, who are passionate about helping patients to understand and live well on their PARP inhibitor. Recorded in February 2023. View our information page on targeted therapies here.

.

.

Treating ovarian cancer with anti-angiogenic agents

A webinar with Professor Gordon Jayson, BM, BA, Bch, FRCP, PhD, Professor of Oncology at The Christie in Manchester, on current research into treating ovarian cancer with anti-angiogenic agents, such as bevacizumab (Avastin). Recorded in November 2020. View our information page on targeted therapies here.

.

.

The effectiveness of bevacizumab (Avastin) and related trials

A webinar with Professor Gordon Jayson, BM, BA, Bch, FRCP, PhD, Professor of Oncology at The Christie in Manchester. Recorded in June 2022. View our information page on targeted therapies here.

.

.

Managing ascites: current and future options

The Ovacome team are joined by Professor Roshan Agarwal and Dr Mohammed Hussain from Northampton General Hospital, to talk about ascites and how its treatment could be improved in the future for ovarian cancer patients. Recorded in March 2021.

.

.

Prehabilitation

A webinar discussing recent research carried out by Rhia Saggu and her colleagues at Imperial College London and the Royal Marsden, to understand more about the factors which influence patient engagement with prehabilitation. Recorded in September 2022.